DB19438InvestigationalProtein Based Therapies
Sabirnetug is under investigation in clinical trial NCT06335173 (A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)).
- Mechanism
- Curator reviewed
Pharmacologically active on Amyloid-beta precursor protein
Resolves to
Compound
Targets
What you can answer from here — as of July 09, 2026
Which drugs share a target with Sabirnetug, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account